Literature DB >> 21822854

The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.

Yeo-Hoon Yoon1, Hak Joon Kim, Jin Woo Lee, Jin Man Kim, Bon Seok Koo.   

Abstract

The goal of this study is to determine the clinicopathologic differences in patients with papillary thyroid carcinoma (PTC) with or without chronic lymphocytic thyroiditis (CLT). We reviewed the medical records of 195 consecutive PTC patients who underwent total thyroidectomy and bilateral central lymph node dissection from April 2008 to March 2010. The differences in clinicopathologic factors, such as age, gender, size of primary tumor, perithyroidal invasion, lymphovascular invasion, capsular invasion, and central lymph node (CLN) metastasis, were analyzed in PTC patients with or without CLT. Among 195 patients, 56 (28.7%) had co-existing CLT. Patients with CLT had the following characteristics as compared to patients without CLT: significantly younger, female predominance, smaller tumor size, and lower incidence of capsular invasion (p = 0.038, 0.006, 0.037, and 0.026, respectively). Also, patients with CLT (12.5%) had a significantly lower incidence of CLN metastases than patients without CLT (28.1%; p = 0.025) based on univariate analysis. Moreover, multivariate analysis showed that younger age (p = 0.042, odds ratio = 1.033) and female gender (p = 0.012, odds ratio = 6.865) are independent clinical factors in patients with CLT compared to patients without CLT. CLT was shown to be commonly associated with PTC. Compared to patients with PTC without CLT, patients with CLT were younger with a female predominance, which are the most important and well-known prognostic variables for thyroid cancer mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21822854     DOI: 10.1007/s00405-011-1732-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.

Authors:  M E DAILEY; S LINDSAY; R SKAHEN
Journal:  AMA Arch Surg       Date:  1955-02

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma.

Authors:  K Kashima; S Yokoyama; S Noguchi; N Murakami; H Yamashita; S Watanabe; S Uchino; M Toda; A Sasaki; T Daa; I Nakayama
Journal:  Thyroid       Date:  1998-03       Impact factor: 6.568

4.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

5.  Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?

Authors:  Daniel Repplinger; Anna Bargren; Yi-Wei Zhang; Joel T Adler; Megan Haymart; Herbert Chen
Journal:  J Surg Res       Date:  2007-10-29       Impact factor: 2.192

6.  Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway.

Authors:  Shawn D Larson; Lindsey N Jackson; Taylor S Riall; Tatsuo Uchida; Robert P Thomas; Suimin Qiu; B Mark Evers
Journal:  J Am Coll Surg       Date:  2007-02-23       Impact factor: 6.113

7.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

8.  Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Yeo-Hoon Yoon; Jin-Man Kim; Eun Chang Choi; Young Chang Lim
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

9.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

Authors:  Giuseppe Mercante; Andrea Frasoldati; Corrado Pedroni; Debora Formisano; Luigi Renna; Simonetta Piana; Giorgio Gardini; Roberto Valcavi; Verter Barbieri
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

10.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

View more
  28 in total

1.  Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.

Authors:  Husniye Baser; Didem Ozdemir; Neslihan Cuhaci; Cevdet Aydin; Reyhan Ersoy; Aydan Kilicarslan; Bekir Cakir
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

2.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

3.  Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas.

Authors:  Lucas Leite Cunha; Laura Sterian Ward
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-16       Impact factor: 2.503

4.  Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.

Authors:  Cosimo Durante; Sara Tognini; Teresa Montesano; Fabio Orlandi; Massimo Torlontano; Efisio Puxeddu; Marco Attard; Giuseppe Costante; Salvatore Tumino; Domenico Meringolo; Rocco Bruno; Fabiana Trulli; Maria Toteda; Adriano Redler; Giuseppe Ronga; Sebastiano Filetti; Fabio Monzani
Journal:  Thyroid       Date:  2014-05-21       Impact factor: 6.568

Review 5.  The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution.

Authors:  Antonio Ieni; Valeria Barresi; Roberta Cardia; Luana Licata; Flavia Di Bari; Salvatore Benvenga; Giovanni Tuccari
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

6.  Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.

Authors:  Xiaoyu Wu; Yu Lun; Han Jiang; Qingwei Gang; Shijie Xin; Zhiquan Duan; Jian Zhang
Journal:  Endocrine       Date:  2013-12-14       Impact factor: 3.633

7.  The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.

Authors:  Inhwa Lee; Hyeung Kyoo Kim; Euy Young Soh; Jeonghun Lee
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

8.  The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.

Authors:  Murat Kapan; Akin Onder; Sadullah Girgin; Burak Veli Ulger; Ugur Firat; Omer Uslukaya; Abdullah Oguz
Journal:  Int Surg       Date:  2015-02

Review 9.  Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies.

Authors:  Francesco Boi; Fabiana Pani; Stefano Mariotti
Journal:  Eur Thyroid J       Date:  2017-04-24

10.  Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?

Authors:  Hee Yong Kwak; Byung Joo Chae; Yong Hwa Eom; Young Ran Hong; Jae Beom Seo; So Hee Lee; Byung Joo Song; Sang Seol Jung; Ja Seong Bae
Journal:  Int J Clin Oncol       Date:  2014-10-15       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.